REFERENCES
1. Ng M, Gakidou E, Lo J, et al. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405:813-38.
2. Kerr JA, Patton GC, Cini KI, et al. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405:785-812.
3. Dörr M. Big data and cardiovascular risk—insights into obesity, diabetes, and coronary heart disease. Herz. 2025;50:260-7.
5. Zhou X, Targher G, Byrne CD, Shapiro MD, Chen L, Zheng M. Metabolic dysfunction-associated fatty liver disease: bridging cardiology and hepatology. Cardiol Plus. 2024;9:275-82.
6. Zisis K, Athanasakis K. Obesity in childhood and adolescence: epidemiology and financial implications. Horm Res Paediatr. 2025;99:169-74.
8. Kent L, Mcgirr M, Eastwood K. Global trends in prevalence of maternal overweight and obesity: A systematic review and meta-analysis of routinely collected data retrospective cohorts. Int J Popul Data Sci. 2024;9:2401.
9. Wierzchowska-Opoka M, Domańska A, Masiarz A, Olbrot N, Oleszczuk A. Metabolic roles of fatty acid binding protein 4 (FABP4) in fetal and maternal health and maintenance of pregnancy in women with obesity: a review. Med Sci Monit. 2025;31:947679.
10. Wang L, O'kane AM, Zhang Y, Ren J. Maternal obesity and offspring health: adapting metabolic changes through autophagy and mitophagy. Obes Rev. 2023;24:e13567.
11. Armitage JA, Poston L, Taylor PD. Developmental origins of obesity and the metabolic syndrome: the role of maternal obesity. Front Horm Res. 2008;36:73-84.
12. Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221-62.
13. De Oliveira MP, Da Silva LE, Fernandes BB, et al. The impact of obesity on mitochondrial dysfunction during pregnancy. Mol Cell Endocrinol. 2025;598:112463.
14. Zatterale F, Longo M, Naderi J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020;10:1607.
15. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Investig. 2006;116:3015-25.
16. Reyna SM, Ghosh S, Tantiwong P, et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes. 2008;57:2595-602.
17. Mhatre UA, Jindal I, Mojavery A, et al. The role of polyunsaturated fatty acids in neurodevelopmental pediatric outcomes in the settings of gestational diabetes and obesity: a comprehensive review. Neuroscience. 2025;579:227-38.
18. Guillaumin MCC, Peleg-Raibstein D. Maternal over- and malnutrition and increased risk for addictive and eating disorders in the offspring. Nutrients. 2023;15:51095.
19. Seneviratne SN, Rajindrajith S. Fetal programming of obesity and type 2 diabetes. World J Diabetes. 2022;13:482-97.
20. Peleg-Raibstein D. Understanding the link between maternal overnutrition, cardio-metabolic dysfunction and cognitive aging. Front Neurosci. 2021;15:645569.
21. Turdi S, Ge W, Hu N, Bradley KM, Wang X, Ren J. Interaction between maternal and postnatal high fat diet leads to a greater risk of myocardial dysfunction in offspring via enhanced lipotoxicity, IRS-1 serine phosphorylation and mitochondrial defects. J Mol Cell Cardiol. 2013;55:117-29.
22. Dong M, Zheng Q, Ford SP, Nathanielsz PW, Ren J. Maternal obesity, lipotoxicity and cardiovascular diseases in offspring. J Mol Cell Cardiol. 2013;55:111-6.
23. Wu L, Zhang Y, Wang G, Ren J. Molecular mechanisms and therapeutic targeting of ferroptosis in doxorubicin-induced cardiotoxicity. JACC Basic Transl Sci. 2024;9:811-26.
24. Ajoolabady A, Aslkhodapasandhokmabad H, Libby P, et al. Ferritinophagy and ferroptosis in the management of metabolic diseases. Trends Endocrinol Metab. 2021;32:444-62.
25. Larsen TD, Sabey KH, Knutson AJ, et al. Diabetic pregnancy and maternal high-fat diet impair mitochondrial dynamism in the developing fetal rat heart by sex-specific mechanisms. Int J Mol Sci. 2019;20:3090.
26. Yujiao C, Meng Z, Shanshan L, Wei W, Yipeng W, Chenghong Y. Exposure to bisphenol a induces abnormal fetal heart development by promoting ferroptosis. Ecotoxicol Environ Saf. 2023;255:114753.
27. Fisher AL, Sangkhae V, Balušíková K, Palaskas NJ, Ganz T, Nemeth E. Iron-dependent apoptosis causes embryotoxicity in inflamed and obese pregnancy. Nat Commun. 2021;12:4026.
28. Huang Y, Yan X, Zhao JX, et al. Maternal obesity induces fibrosis in fetal myocardium of sheep. Am J Physiol Endocrinol Metab. 2010;299:E968-75.
29. Wang Q, Zhu C, Sun M, et al. Maternal obesity impairs fetal cardiomyocyte contractile function in sheep. FASEB J. 2018;33:2587-98.
30. Fan X, Turdi S, Ford SP, et al. Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheep. J Nutr Biochem. 2011;22:30-7.
31. Zhuang Z, Zhu Y, Tao J, et al. UCF101 rescues against diabetes-evoked cardiac remodeling and contractile anomalies through AMP-activated protein kinase-mediated induction of mitophagy. Pharmacology. 2024;110:127-40.
32. Yang L, Ma J, Tan Y, et al. Cardiac‐specific overexpression of metallothionein attenuates L‐NAME‐induced myocardial contractile anomalies and apoptosis. J Cell Mol Med. 2019;23:4640-52.
33. Wang J, Ma H, Tong C, et al. Overnutrition and maternal obesity in sheep pregnancy alter the JNK‐IRS‐1 signaling cascades and cardiac function in the fetal heart. FASEB J. 2010;24:2066-76.
34. Zhu M, Du M, Nathanielsz P, Ford S. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta. 2010;31:387-91.
35. Yan X, Zhu MJ, Xu W, et al. Up-regulation of toll-like receptor 4/nuclear factor-κB signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese sheep at late gestation. Endocrinology. 2010;151:380-7.
36. Huang Y, Yan X, Zhu MJ, et al. Enhanced transforming growth factor-β signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation. Am J Physiol Endocrinol Metab. 2010;298:E1254-60.
37. Yan X, Huang Y, Wang H, et al. Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep. Inflamm Bowel Dis. 2011;17:1513-22.
38. Yan X, Huang Y, Zhao J, et al. Maternal obesity-impaired insulin signaling in sheep and induced lipid accumulation and fibrosis in skeletal muscle of offspring1. Biol Reprod. 2011;85:172-8.
39. Long NM, George LA, Uthlaut AB, et al. Maternal obesity and increased nutrient intake before and during gestation in the ewe results in altered growth, adiposity, and glucose tolerance in adult offspring1. J Anim Sci. 2010;88:3546-53.
40. Wallace J, Luther J, Milne J, et al. Nutritional modulation of adolescent pregnancy outcome - a review. Placenta. 2006;27:61-8.
41. Tallarek AC, Zeller T, Goßling A, et al. High‐sensitivity CRP is elevated in pregnant women with overweight and obesity and modulated by gestational weight gain. Acta Obstet Gynecol Scand. 2025;104:1339-46.
42. Loperfido F, Sottotetti F, Bianco I, et al. Folic acid supplementation in European women of reproductive age and during pregnancy with excessive weight: a systematic review. Reprod Health. 2025;22:13.
43. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr Mice: mutations in Tlr4 gene. Science. 1998;282:2085-8.
44. Lee JY, Ye J, Gao Z, et al. Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem. 2003;278:37041-51.
45. Esposito K, Marfella R, Giugliano D. Plasma interleukin-18 concentrations are elevated in type 2 diabetes. Diabetes Care. 2004;27:272.
